Lv1
8 积分 2025-09-02 加入
Switch to fixed-dose doravirine (100 mg) and islatravir (0·25 mg) once daily in virologically suppressed adults with HIV-1 on bictegravir, emtricitabine, and tenofovir alafenamide: 48-week results of a phase 3, multicentre, randomised, controlled, double-blind, non-inferiority trial
1个月前
已完结
Excessive autophagic degradation of MYLK3 causes sunitinib-induced cardiotoxicity
1年前
已完结
皖公网安备34019202002308
